pI: 9.7793 |
Length (AA): 1462 |
MW (Da): 164448 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
326 | 1031 | 1gm5 (A) | 23 | 705 | 14.00 | 0 | 0.99 | 0.52 | 1.26 |
363 | 1260 | 2eyq (A) | 293 | 1145 | 11.00 | 0 | 1 | 0.32 | 1.17 |
670 | 879 | 1vec (A) | 86 | 288 | 33.00 | 0 | 1 | 0.76 | -2.24 |
674 | 1293 | 2eyq (A) | 583 | 1147 | 17.00 | 0 | 1 | 0.53 | 0.4 |
3 | 101 | 4wik (A) | 498 | 597 | 21.00 | 0.49 | 0 | 0.407215 | -1.67 |
513 | 550 | 2kpy (A) | 63 | 103 | 50.00 | 0.22 | 0.01 | 0.577092 | -1.27 |
624 | 1059 | 4lk2 (B) | 210 | 667 | 38.00 | 0 | 1 | 0.807322 | -0.76 |
629 | 881 | 4a4d (A) | 55 | 303 | 45.00 | 0 | 1 | 0.843151 | -1.37 |
671 | 880 | 3ber (A) | 26 | 228 | 33.00 | 0 | 1 | 0.710739 | -1.74 |
1226 | 1451 | 4tql (A) | 10 | 224 | 14.00 | 0.41 | 0.03 | 0.189583 | -0.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127962)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G09620 | DEAD-box ATP-dependent RNA helicase 45 |
Arabidopsis thaliana | AT1G20920 | DEAD Box RNA Helicase RCF1 |
Babesia bovis | BBOV_I004920 | DEAD/DEAH box helicase and helicase conserved C-terminal domain containing protein |
Brugia malayi | Bm1_39745 | KIAA0801 protein |
Candida albicans | CaO19.14123 | spliceosomal RNA helicase |
Candida albicans | CaO19.6831 | spliceosomal RNA helicase |
Caenorhabditis elegans | CELE_F53H1.1 | Protein F53H1.1 |
Cryptosporidium hominis | Chro.80099 | ATP-dependent RNA helicase |
Cryptosporidium parvum | cgd8_800 | Prp5p C terminal KH. eIF4A-1-family RNA SFII helicase |
Dictyostelium discoideum | DDB_G0275443 | DEAD/DEAH box helicase |
Drosophila melanogaster | Dmel_CG6227 | CG6227 gene product from transcript CG6227-RA |
Echinococcus granulosus | EgrG_001058000 | ATP dependent RNA helicase DDX46 |
Entamoeba histolytica | EHI_013960 | DEAD/DEAH box helicase, putative |
Echinococcus multilocularis | EmuJ_001058000 | ATP dependent RNA helicase DDX46 |
Homo sapiens | ENSG00000145833 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
Leishmania braziliensis | LbrM.08.0080 | ATP-dependent DEAD/H RNA helicase, putative |
Leishmania donovani | LdBPK_080080.1 | ATP-dependent DEAD/H RNA helicase, putative |
Leishmania infantum | LinJ.08.0080 | ATP-dependent DEAD/H RNA helicase, putative |
Leishmania major | LmjF.08.0080 | ATP-dependent DEAD/H RNA helicase, putative |
Leishmania mexicana | LmxM.08.0080 | ATP-dependent DEAD/H RNA helicase, putative |
Loa Loa (eye worm) | LOAG_00736 | RNA helicase |
Mus musculus | ENSMUSG00000021500 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
Neospora caninum | NCLIV_005180 | hypothetical protein |
Oryza sativa | 4344716 | Os08g0159900 |
Onchocerca volvulus | OVOC5073 |
|
Plasmodium berghei | PBANKA_1108300 | pre-mRNA-processing ATP-dependent RNA helicase PRP5, putative |
Plasmodium falciparum | PF3D7_0508700 | pre-mRNA-processing ATP-dependent RNA helicase PRP5, putative |
Plasmodium knowlesi | PKNH_1024900 | pre-mRNA-processing ATP-dependent RNA helicase PRP5, putative |
Plasmodium vivax | PVX_097995 | ATP-dependent RNA helicase, putative |
Plasmodium yoelii | PY05239 | similar to RNA helicases, putative |
Saccharomyces cerevisiae | YBR237W | DEAD-box RNA helicase PRP5 |
Schistosoma japonicum | Sjp_0313390 | expressed protein |
Schistosoma mansoni | Smp_174210.1 | DEAD box ATP-dependent RNA helicase |
Schistosoma mansoni | Smp_174210.2 | DEAD box ATP-dependent RNA helicase |
Schistosoma mansoni | Smp_174210.3 | DEAD box ATP-dependent RNA helicase |
Schmidtea mediterranea | mk4.004776.00 | Probable ATP-dependent RNA helicase DDX46 |
Schmidtea mediterranea | mk4.017211.00 | |
Schmidtea mediterranea | mk4.000410.01 | |
Trypanosoma brucei gambiense | Tbg972.5.5020 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma brucei | Tb927.5.3600 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma congolense | TcIL3000_0_04480 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma congolense | TcIL3000_5_4040 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma cruzi | TcCLB.507811.30 | ATP-dependent DEAD/H RNA helicase, putative |
Trypanosoma cruzi | TcCLB.511649.169 | ATP-dependent DEAD/H RNA helicase, putative |
Toxoplasma gondii | TGME49_221660 | DEAD/DEAH box helicase domain-containing protein |
Theileria parva | TP03_0532 | ATP-dependent RNA helicase, putative |
Theileria parva | TP03_0533 | hypothetical protein |
Trichomonas vaginalis | TVAG_283670 | DEAD box ATP-dependent RNA helicase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.3600 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.3600 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.3600 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.3600 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F53H1.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F53H1.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F53H1.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F53H1.1 | Caenorhabditis elegans | sterile | wormbase |
YBR237W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1108300 | Plasmodium berghei | Essential | plasmo |
TGME49_221660 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.